GSK 690693 937174-76-0 GSK 690693 supplier GSK 690693 seller
We have been providing over 1000 products including molecular targeted anticancer drugs, cell signaling pathway
inhibitors, pharmaceutical intermediates, and heterocyclic compounds, and quality services including custom
synthesis, transfer of new drug patent and technology, technical cooperation, and process optimization.
Jinan Trio PharmaTech was founded by a core group of top overseas pharmaceutical chemists, Medical scientists and
business management experts, and is an enterprise of science and technology supported by the "Attracting High-
Level Talent Scheme" of Jinan government.
Jinan Trio PharmaTech Co., Ltd.
Year Establishment: 2008
Location: We are located at one of the largest National Technical Integrated Drug Discovery Platforms in the High-Tech Zone of Jinan City
Our company was founded by a core group of top overseas pharmaceutical chemists, medical scientists business
management experts
We have built up solid cooperation with over twenty oversea companies over one hundred domestic companies
since the foundation
Specifications:
Name GSK 690693
Synonyms 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol
Molecular Formula C21H27N7O3
Molecular Weight 425.48
CAS Registry Number 937174-76-0
Applications:
GSK690693 is a pan-Akt inhibitor targeting Akt1, Akt2 and Akt3 with IC50 of 2 nM, 13 nM, and 9 nM, respectively
About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia
Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog
©2008 LookChem.com,License: ICP
NO.:Zhejiang16009103
complaints:service@lookchem.com Desktop View